[Sensitivity of nosocomial microflora circulating in a transplantation clinic to medicinal bacteriophages]

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|January 8, 2005
PubMed

Insights

Phage therapy effectiveness varies among bacterial isolates from postoperative infections. Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli showed the highest sensitivity to specific bacteriophages, indicating potential for phage-based treatments.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Bacteriophage Research

Background:

  • Postoperative infectious complications pose a significant clinical challenge.
  • Bacteriophage therapy offers a potential alternative or adjunct to antibiotics.
  • Understanding bacterial susceptibility to phages is crucial for therapeutic application.

Purpose of the Study:

  • To determine the sensitivity of bacterial isolates from postoperative infections to phagolysis.
  • To identify key bacterial species exhibiting high sensitivity to bacteriophages.
  • To investigate variations in phage sensitivity based on phage origin.

Main Methods:

  • Collected 239 bacterial isolates from patients with postoperative infectious complications.
  • Assessed the sensitivity of these isolates to various bacteriophages (phagolysis).
  • Compared sensitivity across different bacterial species and phage sources.

Main Results:

  • Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli demonstrated the highest sensitivity to bacteriophages.
  • Significant variations in isolate sensitivity were observed even for phages from the same producer.
  • Identified differences in sensitivity profiles depending on the bacteriophage source.

Conclusions:

  • Bacteriophage therapy holds promise for treating specific postoperative infections caused by S. aureus, P. aeruginosa, and E. coli.
  • Phage sensitivity testing is essential due to variability in efficacy.
  • Bacterial sensitivity to phages can serve as a marker for biological strain properties.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Bacteriophages of the Human Virome01:23

Bacteriophages of the Human Virome

Bacteriophages are found throughout the human body. They may even outnumber eukaryotic viruses, forming an important and dynamic component of the human virome. Indeed, phages represent the most abundant viral entities, with densities in the gut reaching up to 10⁹ particles per gram of fecal matter, and many belonging to orders such as Caudovirales and Microviridae, while a substantial proportion remains unclassified as viral “dark matter.”Lysogeny and Genetic ExchangeIn the gut, bacteriophages...